Sleep Disorders Trial, Recruiting NCT07292922 Sponsor: Hong Kong Metropolitan University Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT07292922
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who have been diagnosed with mild to moderate Obstructive Sleep Apnoea, meaning their sleep test showed between 5 and 30 breathing interruptions per hour
  • People whose doctor has recommended a CPAP machine or a mouth device for their sleep apnoea, but who are unable to tolerate or have chosen not to use these treatments
  • People with a body mass index (a measure of body weight relative to height) below 30

Who may not be able to join:

  • People who have a blocked or diseased nasal passage that significantly affects breathing through the nose
  • People with unstable mental health conditions
  • People who have had a stroke
  • People with unstable long-term conditions affecting the lungs, heart, or nervous system
  • People who are not able to give their own informed consent to participate
  • People who have previously had surgery on the mouth, throat, or jaw area to treat sleep apnoea

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Agnes YK Lai, PhD, Hong Kong Metropolitan University

Phone: (852)3970-2917

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hong Kong Metropolitan University
Registry
ClinicalTrials.gov
Start date
5 January 2026
Est. completion
31 January 2027

Where this trial is recruiting

Hong Kong

Primary endpoints

Programme satisfaction; Change in oxygen saturation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov